Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Blood Cancer
- Chemotherapy and Radiotherapy
- Endometrial Cancer
- Carcinomas
- Paediatric Cancers
- Surgical Oncology
- Gynecological Cancers
- Cervical Cancer
Abstract
Citation: Clin Oncol. 2016;1(1):1037.DOI: 10.25107/2474-1663.1037
Splenectomy Tonsillectomy and Appendectomy - Complications and Cancer Occurrence
Benharroch D, Nalbandyan K, Kraus M, Osyntsov A and Ariad S
Department of Pathology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of ENT, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of Surgery B, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel
*Correspondance to: Daniel Benharroch
PDF Full Text Case Report | Open Access
Abstract:
The removal of secondary lymphoid tissue is not innocuous. Infectious complications in procedures such as total splenectomies are frequent and may be fatal. Sequelae may be thromboembolic. Immune alterations are expected after such procedures. The most controversial consequence, one that is linked with immune changes, is the development of malignant tumors. Regarding post-splenectomy malignancies, there appears to be marked discrepancies between the increased occurrence of tumors in humans and the protective effects seen in experimental animals. It is recommended, that surgeons strive to preserve as much lymphoid tissue as possible.
Keywords:
Cite the Article:
Benharroch D, Nalbandyan K, Kraus M, Osyntsov A, Ariad S. Splenectomy Tonsillectomy and Appendectomy - Complications and Cancer Occurrence. Clin Oncol. 2016; 1: 1037.